Yasser Mostafa Kamel

Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial

Harry P. Erba, Pau Montesinos, Hee‐Je Kim et al. · The Lancet · 2023 · 319 citations

Hematological Malignancy, Medicine, Hematology +5

Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy

Nezam H. Afdhal, Geoffrey Dusheiko, Edoardo G. Giannini et al. · Gastroenterology · 2013 · 138 citations · Full text

Thrombopoiesis, Thrombosis, Hcv Infection +11

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial

Uwe Platzbecker, Raymond Wong, Amit Verma et al. · The Lancet Haematology · 2015 · 79 citations

Eltrombopag Versus Placebo, Thrombosis, Hematological Malignancy +12

A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors

A. Kellum, Agnieszka Jagiełło-Gruszfeld, Igor Bondarenko et al. · Current Medical Research and Opinion · 2010 · 60 citations

Eltrombopag with gemcitabine‐based chemotherapy in patients with advanced solid tumors: a randomized phase I study

Eric S. Winer, Howard Safran, Bogusława Karaszewska et al. · Cancer Medicine · 2014 · 56 citations · Full text